CBIO
Crescent Biopharma
CBIO
CBIO
58 hedge funds and large institutions have $286M invested in Crescent Biopharma in 2025 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% more funds holding
Funds holding: 41 → 58 (+17)
Holders
58
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$34.6M | |
| 2 | +$21.4M | |
| 3 | +$19.1M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$17.3M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$17.3M |
Top Sellers
| 1 | -$5.36M | |
| 2 | -$3.25M | |
| 3 | -$2.38M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$2.38M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.28M |
